WuXi XDC

Unlock your potential with WuXi XDC's end-to-end discovery, development, and manufacturing services for ADCs and bioconjugates! Our integrated, comprehensive platform can accelerate your path to the clinic and beyond by providing enhanced efficiency, flexibility, lowered risks, fewer costs, and industry-leading timelines. Find more detail insights into our services, explore here: https://lnkd.in/dqX-2YXr #conjugate #conjugates #bioconjugation #bioconjugate #bioconjugates #adc #adcs #antibodydrugcongugate #antibodydrugcongugates #cmc #cdmo #crdmo #biomanufacturing #bioprocessing

Join us BIO Asia–Taiwan 2024, our experts are looking forward to meeting you there, and discussing the innovative solutions and services we offer across WuXi XDC and how we can help advance your drug development goals.

Do you have what you need to develop an ADC? WuXi XDC, a global leading bioconjugation CRDMO, enables ADC/Bioconjugate developers to enter the clinic and market more efficiently and cost-effectively, has empowered 345 global partners, 140 integrated CMC projects and 55 IND submissions, we offer an unprecedented single-source approach for ADC/Bioconjugate discovery, development and manufacturing, contact us to discuss your bioconjugation projects' needs: https://lnkd.in/eCgHTVqf #bioconjugation #biomanufacturing #biopharma #biologics #biotherapeutics #ADC #adcs #antibodydrugconjugate #antibodydrugconjugates #ADCdisocvery #ADCdevelopment #ADCmanufacturing

At WuXi XDC, we have established industry-leading development know-how for a wide variety of bioconjugates across all aspects of conjugation process development (PD), analytical development and formulation and drug product (DP) process development. By partnering with WuXi XDC, and utilizing our single-source development expertise, state-of-the-art conjugation technologies and streamlined development processes, we can help you advance your bioconjugates into the clinic and beyond. Explore more: https://lnkd.in/gcxBEs37 #bioconjugation #biomanufacturing #biopharma #biologics #biotherapeutics #ADC #antibodydrugconjugate #BioconjugationProcessDevelopment #ProcessDevelopment

ADCs and other bioconjugates constitute a unique and complex drug modality distinct from both biologics and small molecules. This complexity leads to multiple challenges due to not only the multipart intermediates development activities but also the inherent complexity involved in the major steps of the bioconjugation development process. To meet all your preclinical and late-stage bioconjugate process development needs, WuXi XDC provides state-of-the-art technologies, world-class expertise and vast hands-on experience. Our high-quality bioconjugation process development capabilities along with our extensive and integrated purification process development, process scale-up, and tech-transfer to GMP manufacturing services will accelerate your program towards the clinic and beyond. Access our process development capabilities to discover how we can help advance your bioconjugate to next milestone! https://lnkd.in/er7pH2pp #bioconjugation #biomanufacturing #biopharma #biologics #biotherapeutics #ADC #antibodydrugconjugate #BioconjugationProcessDevelopment #ProcessDevelopment

Process Characterization (PC) should be performed with qualified scale-down model prior to process performance qualification (PPQ) manufacturing as part of the validation package in a BLA. WuXi XDC’s PD team has strong CMC expertise to accelerate ADC to BLA. PC studies and late-phase development have been finished by WuXi XDC for 10 ADCs projects. Contact us to learn more: https://lnkd.in/er7pH2pp #bioconjugation #biomanufacturing #biopharma #biologics #biotherapeutics #ADC #adcs #antibodydrugconjugate #antibodydrugconjugates #BioconjugationProcessDevelopment #ProcessDevelopment

As more ADC modalities are advanced from the preclinical candidate stage into the Chemistry Manufacturing Control (CMC) development stage, process development scientists are facing tremendous challenges such as the need for larger-scale and more consistent CMC processes. At WuXi XDC, our experienced experts specialized in consistent and scalable conjugation and purification have delivered 100 processes within aggressive timelines to support IND filing or to conduct process characterization activities for programs towards a BLA submission. This poster presents case studies of the solutions established for challenging process development projects. Click here to access the scientific poster and learn more details: https://lnkd.in/gc_4c-XY #bioconjugation #biomanufacturing #biopharma #biologics #biotherapeutics #ADC #antibodydrugconjugate #BioconjugationProcessDevelopment #ProcessDevelopment

With 40 clients' products currently in clinical trials, we have extensive experience to optimize your clinical bioconjugation process. We focus on process improvements in： √ higher productivity, lower CoGs √ product quality consistency √ process robustness and scalibility √ security of supply Contact us to discuss your needs: https://lnkd.in/gPPyFxjH #bioconjugation #biomanufacturing #biopharma #biologics #biotherapeutics #ADC #antibodydrugconjugate #ADCs #antibodydrugconjugates #BioconjugationProcessDevelopment #ProcessDevelopment

Time, Cost, and Quality are crucial along with the Bioconjugates Development. Partner with WuXi XDC, we can rapidly develop and streamline your bioconjugate CMC development and GMP manufacturing! Our integrated, single-source and streamlined WuXi XDC platform provides efficient project management, extensive expertise and premier world-class quality systems that result in right-first-time execution and provide industry leading 13-15 month DNA to IND timelines. with WuXi XDC powerful platform, we offer you: √ Much faster time to IND: cuts timeline by ~50% √ Reduced costs √ Consistent, high quality across mAb/LP/DS/DP Contact us to learn more! https://wuxixdc.com/ #antibodydrugconjugates #ADC #R&D #CMCdevelopment #BioconjugateDevelopment #IND #GMPmanufacturing

Our team had a wonderful experience at World ADC Asia World ADC Event Series this week, where we had the opportunity to connect with so many industry clients. Dr. Jimmy L., CEO of WuXi XDC, delivered an insightful speech on June 27th. During his talk, Dr. Jimmy L. showcased our industry leading CRDMO platform, which offers comprehensive and fully integrated development and manufacturing services on all ADC components. He emphasized that our fully-integrated platform ensures the fastest route to IND with 15 months or even less from DNA synthesis to IND filing, with over 60 successful IND submissions to date. Furthermore, Dr. Jimmy Li elucidated that accelerated timeline for late stage development to BLA submission is essential for ADCs companies seeking for expedited development and approvals. Leveraging our vast experience and expertise, coupled with our comprehensive manufacturing capabilities that encompass all ADC components, WuXi XDC is committed to providing a clear and strategic pathway for the extensive journey towards BLA. Explore more: https://wuxixdc.com/ #bioconjugation #biomanufacturing #biopharma #biologics #biotherapeutics #ADC #antibodydrugconjugate #ADCdisocvery #ADCdevelopment #ADCmanufacturing